Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy?

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

309

HTML

1498

Figures (1-2)

207

Tables (1-1)

196

Sum=2210

Jul 14, 2007 (publication date) through Nov 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 14, 2007; 13(26): 3605-3609
Published online Jul 14, 2007. doi: 10.3748/wjg.v13.i26.3605

Table 1 Antibody characteristics

Target	Antibody	Dilution	Incubation
VEGFR1	Flt-1 (C-17)	1:100	4 h	Santa Cruz, Biotechnology, CA, USA
VEGFR3	Flt-4 (C20)	1:200	2 h	Santa Cruz, Biotechnology, CA, USA
PDGFRα	PDGFRα (C-20)	1:200	2 h	Santa Cruz, Biotechnology, CA, USA
PDGFRβ	PDGFRβ (28 E1)	1:200	2 h	Cell Signalling Technology, MA, USA
EGFR1	AM207-5ME	1:1	1 h	BioGenex, CA, USA

Citation: Drescher D, Moehler M, Gockel I, Frerichs K, Müller A, Dünschede F, Borschitz T, Biesterfeld S, Holtmann M, Wehler T, Teufel A, Herzer K, Fischer T, Berger MR, Junginger T, Galle PR, Schimanski CC. Coexpression of receptor-tyrosine-kinases in gastric adenocarcinoma-a rationale for a molecular targeting strategy? World J Gastroenterol 2007; 13(26): 3605-3609
URL: https://www.wjgnet.com/1007-9327/full/v13/i26/3605.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i26.3605